QMS Medical Allied Services Limited Stock Price Today (NSE: QMSMEDI)
QMS Medical Allied Services Limited
Fundamental Score
QMS Medical Allied Services Limited Share Price Live NSE/BSE & Institutional Fundamental Analysis
QMS Medical Allied Services Limited share price today is ₹92.00, up +0.00% on NSE/BSE as of 17 February 2026. QMS Medical Allied Services Limited (QMSMEDI) is a Small-cap company in the Medical Equipment & Supplies sector with a market capitalisation of ₹189.41 (Cr). The 52-week high for QMSMEDI share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 15.39x, QMSMEDI is currently trading below its industry average P/E of 47.87x. The company has a Return on Equity (ROE) of 14.36% and a debt-to-equity ratio of 0.55.
QMS Medical Allied Services Limited Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
QMS Medical Allied Services Limited Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
QMS Medical Allied Services Share Price: A Financial Stability Analysis
The medical equipment and supplies sector is currently experiencing robust growth, fueled by an aging global population and increasing demand for advanced healthcare solutions. This creates a dynamic environment for companies like QMS Medical Allied Services Limited. This financial analysis examines the stability of the "QMS Medical Allied Services share price", currently at ₹87.3499984741211, based on key financial metrics and a comparative assessment with its peers. The current Price-to-Earnings (PE) ratio for QMS Medical Allied Services is 15.39, suggesting a valuation relative to its earnings.
A critical aspect of financial health is Return on Capital Employed (ROCE). QMS Medical Allied Services boasts a ROCE of 16.6%. This indicates the company's efficiency in generating profits from its capital investments. A higher ROCE generally signifies stronger profitability and better utilization of resources. This strong ROCE contributes to building a potential economic moat around the company, as it demonstrates an ability to generate superior returns compared to competitors, potentially discouraging new entrants and fostering long-term sustainability.
Comparing QMS Medical Allied Services Limited to its peers is crucial. Consider
Choksi Asia. While a quantitative comparison of financial metrics is important, assessing management quality is more subjective, often relying on factors like strategic decision-making, operational efficiency, and corporate governance practices. Evaluating these aspects, along with comprehensive due diligence, offers a more holistic view of the company's potential for sustained performance.This analysis is based on publicly available data and is intended for informational purposes only. The current QMS Medical Allied Services share price and associated metrics are subject to market fluctuations and evolving business conditions. This analysis forms a single component within a comprehensive 80-parameter fundamental audit, meticulously verified by Sweta Mishra, to ensure a robust and multi-faceted evaluation of the company's overall financial health. No recommendations, either to buy or sell QMS Medical Allied Services shares, are expressed or implied in this analysis.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
QMS Medical Allied Services Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of QMSMEDI across key market metrics for learning purposes.
Positive Indicators
5 factors identified
Excellent ROCE Performance (16.60%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Attractive Valuation (P/E: 15.39 vs Industry: 47.87)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Strong Revenue Growth (20.16%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Balanced Promoter Holding (68.11%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
1 factors identified
Limited Institutional Interest (FII+DII: 1.61%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
QMS Medical Allied Services Limited Financial Statements
Comprehensive financial data for QMS Medical Allied Services Limited including income statement, balance sheet and cash flow
About QMSMEDI (QMS Medical Allied Services Limited)
QMS Medical Allied Services Limited (QMSMEDI) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Medical Equipment & Supplies sector with a current market capitalisation of ₹189.41 (Cr). QMS Medical Allied Services Limited has delivered a Return on Equity (ROE) of 14.36% and a ROCE of 16.60%. The debt-to-equity ratio stands at 0.55, reflecting the company's capital structure. Investors tracking QMSMEDI share price can monitor key metrics including P/E ratio, promoter holding of 68.11%, and quarterly earnings growth.
Company Details
QMSMEDI Share Price: Frequently Asked Questions
What is the current share price of QMS Medical Allied Services Limited (QMSMEDI)?
As of 17 Feb 2026, 10:19 am IST, QMS Medical Allied Services Limited share price is ₹92.00. The QMSMEDI stock has a market capitalisation of ₹189.41 (Cr) on NSE/BSE.
Is QMSMEDI share price Overvalued or Undervalued?
QMSMEDI share price is currently trading at a P/E ratio of 15.39x, compared to the industry average of 47.87x. Based on this relative valuation, the QMS Medical Allied Services Limited stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of QMSMEDI share price?
The 52-week high of QMSMEDI share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the QMS Medical Allied Services Limited share price?
Key factors influencing QMSMEDI share price include quarterly earnings growth (Sales Growth: 20.16%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is QMS Medical Allied Services Limited a good stock for long-term investment?
QMS Medical Allied Services Limited shows a 5-year Profit Growth of N/A% and an ROE of 14.36%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.55 before investing in QMSMEDI shares.
How does QMS Medical Allied Services Limited compare with its industry peers?
QMS Medical Allied Services Limited competes with major peers in the Medical Equipment & Supplies. Investors should compare QMSMEDI share price P/E of 15.39x and ROE of 14.36% against the industry averages to determine competitive standing.
What is the P/E ratio of QMSMEDI and what does it mean?
QMSMEDI share price has a P/E ratio of 15.39x compared to the industry average of 47.87x. Investors pay ₹15 for every ₹1 of annual earnings.
How is QMSMEDI performing according to Bull Run's analysis?
QMSMEDI has a Bull Run fundamental score of 29.6/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does QMSMEDI belong to?
QMSMEDI operates in the Medical Equipment & Supplies industry. This classification helps understand the competitive landscape and sector-specific trends affecting QMS Medical Allied Services Limited share price.
What is Return on Equity (ROE) and why is it important for QMSMEDI?
QMSMEDI has an ROE of 14.36%, which shows decent profitability but room for improvement. ROE measures how efficiently QMS Medical Allied Services Limited generates profits from shareholders capital.
How is QMSMEDI debt-to-equity ratio and what does it indicate?
QMSMEDI has a debt-to-equity ratio of 0.55, which indicates moderate leverage that should be monitored.
What is QMSMEDI dividend yield and is it a good dividend stock?
QMSMEDI offers a dividend yield of 0.51%, meaning you receive ₹0.51 annual dividend for every ₹100 invested in QMS Medical Allied Services Limited shares.
How has QMSMEDI share price grown over the past 5 years?
QMSMEDI has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in QMSMEDI and why does it matter?
Promoters hold 68.11% of QMSMEDI shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in QMS Medical Allied Services Limited.
What is QMSMEDI market capitalisation category?
QMSMEDI has a market capitalisation of ₹189 crores, placing it in the Small-cap category.
How volatile is QMSMEDI stock?
QMSMEDI has a beta of N/A. A beta > 1 suggests the QMS Medical Allied Services Limited stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is QMSMEDI operating profit margin trend?
QMSMEDI has a 5-year average Operating Profit Margin (OPM) of N/A%, indicating the company's operational efficiency.
How is QMSMEDI quarterly performance?
Recent quarterly performance shows QMS Medical Allied Services Limited YoY Sales Growth of 20.16% and YoY Profit Growth of -9.30%.
What is the institutional holding pattern in QMSMEDI?
QMSMEDI has FII holding of 0.01% and DII holding of 1.60%. Significant institutional holding often suggests professional confidence in the QMS Medical Allied Services Limited stock.